AR042595A1 - COMPOSITIONS OF MENINGOCOCES WITH ASSISTANT - Google Patents
COMPOSITIONS OF MENINGOCOCES WITH ASSISTANTInfo
- Publication number
- AR042595A1 AR042595A1 ARP020103745A ARP020103745A AR042595A1 AR 042595 A1 AR042595 A1 AR 042595A1 AR P020103745 A ARP020103745 A AR P020103745A AR P020103745 A ARP020103745 A AR P020103745A AR 042595 A1 AR042595 A1 AR 042595A1
- Authority
- AR
- Argentina
- Prior art keywords
- meningococes
- assistant
- compositions
- combination
- neisserial
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title 1
- 241001212279 Neisseriales Species 0.000 abstract 2
- 108091034117 Oligonucleotide Proteins 0.000 abstract 2
- 239000000427 antigen Substances 0.000 abstract 2
- 102000036639 antigens Human genes 0.000 abstract 2
- 108091007433 antigens Proteins 0.000 abstract 2
- 239000011859 microparticle Substances 0.000 abstract 2
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 abstract 1
- 239000002671 adjuvant Substances 0.000 abstract 1
- 229920002988 biodegradable polymer Polymers 0.000 abstract 1
- 239000004621 biodegradable polymer Substances 0.000 abstract 1
Landscapes
- Biological Depolymerization Polymers (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Combinación de oligonucleótidos CpG y micropartículas extremadamente eficaz como adyuvante para antígenos de Neisserial. Una combinación que comprende (a) un antígeno de Neisserial; (b) un oligonucleótido CpG; y (c) una micropartícula polimérica biodegradable.Combination of extremely effective CpG oligonucleotides and microparticles as an adjuvant for Neisserial antigens. A combination comprising (a) a Neisserial antigen; (b) a CpG oligonucleotide; and (c) a biodegradable polymer microparticle.
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US32692901P | 2001-10-03 | 2001-10-03 | |
| PCT/US2002/010869 WO2002080648A2 (en) | 2001-04-05 | 2002-04-05 | Mucosal boosting following parenteral priming |
| US37354702P | 2002-04-17 | 2002-04-17 | |
| US38067702P | 2002-05-13 | 2002-05-13 | |
| US25443802A | 2002-09-24 | 2002-09-24 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR042595A1 true AR042595A1 (en) | 2005-06-29 |
Family
ID=42938593
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP020103745A AR042595A1 (en) | 2001-10-03 | 2002-10-03 | COMPOSITIONS OF MENINGOCOCES WITH ASSISTANT |
Country Status (2)
| Country | Link |
|---|---|
| AR (1) | AR042595A1 (en) |
| MX (1) | MXPA04003186A (en) |
-
2002
- 2002-10-03 MX MXPA04003186A patent/MXPA04003186A/en active IP Right Grant
- 2002-10-03 AR ARP020103745A patent/AR042595A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MXPA04003186A (en) | 2004-07-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR026940A1 (en) | PHARMACEUTICAL COMPOSITION FOR IMMUNOLOGICAL MODULATION AND VACCINE PREPARATION | |
| CO5070674A1 (en) | VACCINES WITH A CPG OLIGONUCLEOTIDE AS AN ASSISTANT | |
| MXPA02008283A (en) | Thermal management system. | |
| BR0213119A (en) | Immunogenic composition and use thereof | |
| DOP2006000050A (en) | A SOLID FORMULATION OF PHARMACEUTICAL DOSAGE | |
| AR074501A1 (en) | IMMUNO STIMULATOR OLIGONUCLEOTIDES | |
| CO5540349A2 (en) | VACCINAL PREPARATION OF INACTIVATED INFLUENZA VIRUS | |
| WO2001078768A3 (en) | Targeted vaccine delivery systems | |
| EP1290928A4 (en) | HEAT SINK AND DEVICE USING THIS | |
| GT200500294A (en) | SEMIBLING C-CLASS IMMUNO-STIMULATOR OLIGONUCLEOTIDES | |
| BR0207279A (en) | Vertebroplasty and bone cement injection device for bone | |
| ATE541587T1 (en) | CONJUGATE ADDITION REACTIONS FOR THE CONTROLLED RELEASE OF PHARMACEUTICALLY ACTIVE SUBSTANCES | |
| PT1187629E (en) | ADJUVANT COMPOSITION THAT UNDERSTANDS SAPONIN AND AN IMMUNOSTIMULATOR OLIGONUCLEOTIDE | |
| EP1318798A4 (en) | WATER-SOLUBLE PROPOFOL PRODRUGS FOR MIGRAINE TREATMENT | |
| ATE426412T1 (en) | ADJUVANT INFLUENZA VACCINE | |
| BRPI0510568A (en) | copolymer, process for preparing same, biodegradable particle, use thereof, process for preparing a release system, perfume composition, and fragrant product | |
| CY1108526T1 (en) | CANCER vaccine | |
| BRPI0508064A (en) | flavivirus, vaccine composition and nucleic acid molecule | |
| ATE419008T1 (en) | ADJUVANT COMPOSITION AND METHOD OF USE THEREOF | |
| ES2171737T3 (en) | METALOCENE-PHOSPHORAMIDITE CONJUGATES, PROCEDURE FOR PRODUCING AND USING THEMSELVES. | |
| PA8571901A1 (en) | NEW PHARMACEUTICAL COMPOSITION | |
| DE60222868D1 (en) | Radiation-curable compositions comprising highly branched, acrylate-terminated, polyesters | |
| AR051385A1 (en) | ISOCIANATE BASED CURTIDE AGENTS | |
| AR042595A1 (en) | COMPOSITIONS OF MENINGOCOCES WITH ASSISTANT | |
| EP1301208A4 (en) | VACCINE |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |